— Know what they know.
Not Investment Advice

NVRO NYSE

Nevro Corp.
1W: -0.2% 1M: +1.9% 3M: +57.0% 1Y: -56.2% 3Y: -91.3% 5Y: -93.5%
$5.84
Last traded 2025-04-02 — delisted
NYSE · Healthcare · Medical - Devices · $224.1M mcap · 34M float · 3.80% daily turnover · Short 35% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$224.1M
52W Range3.165-13.3
Volume751,504
Avg Volume1,299,962
Beta0.82
Dividend—
Analyst Ratings
9 Buy 19 Hold 4 Sell
Consensus Hold
Company Info
CEOKevin R. Thornal
Employees1,099
SectorHealthcare
IndustryMedical - Devices
IPO Date2014-11-06
Websitenevro.com
1800 Bridge Parkway
Redwood City, CA 94065
US
650 251 0005
About Nevro Corp.

Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
GROSSMAN D KEITH D-Return 228,552 $5.85 2025-04-03
Kosaraju Sridhar D-Return 46,575 $5.85 2025-04-03
mcCormick Shawn D-Return 46,035 $5.85 2025-04-03
SIEGEL SUSAN E D-Return 7,382 $5.85 2025-04-03
Karros Kirt P D-Return 17,452 $5.85 2025-04-03

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms